Portal de Periódicos da CAPES

Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety

2023; Elsevier BV; Volume: 45; Linguagem: Inglês

10.1016/j.ijcha.2023.101189

2352-9067

Gregor Goetz, Bernhard Wernly, Claudia Wild,

Atrial Fibrillation Management and Outcomes

To synthesise the available evidence of wearable cardioverter defibrillator (WCD) therapy as an add-on measure to optimal medical therapy (OMT) or as a replacement of hospital stay.